June 3, 2026 Serum Institute of India to manufacture Oxford Ebola vaccine backed by US$ 8.6 million CEPI funding
June 1, 2026 Lab Research Suggests Magnetic Particle Imaging May Help Researchers Find More Effective Ways to Deliver Cell Therapies
June 1, 2026 What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in Congo
June 1, 2026 Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
February 22, 2026 Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)
